✦ LIBER ✦

Cost-effectiveness analysis of LHRH agonists in the treatment of metastatic prostate cancer in Italy

✍ Scribed by S. Iannazzo; L. Pradelli; M. Carsi; M. Perachino

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN8 COST-EFFECTIVENESS ANALYSIS OF LHRH

✍ M Iskedjian; M Hemels; N Iscoe; N Fleshner; T Einarson 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

CN2 COST-UTILITY ANALYSIS OF LHRH AGONIS

✍ M Hemels; M Iskedjian; N Iscoe; N Fleshner; T Einarson 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

Long-term treatment with the LHRH-agonis

✍ Schröder, F.H.; Debruyne, F.J.M.; de Voogt, H.J.; Klijn, J.G.; de Jong, F.H. 📂 Article 📅 1986 🏛 Elsevier Science ⚖ 139 KB

New therapeutic options in metastatic ca

✍ Wilson, L.; Tang, J.; Zhong, L.; Balani, G.; Gipson, G.; Xiang, P.; Yu, D.; Srin 📂 Article 📅 2013 🏛 SAGE Publications 🌐 English ⚖ 296 KB

PCN122 COST-EFFECTIVENESS ANALYSIS OF HO

✍ S Iannazzo; L Pradelli; M Perachino 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

Patient compliance in treatment of prost

✍ J.Anthony Shaheen; Mohammad Amin; James I. Harty 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 311 KB